1,045
Views
4
CrossRef citations to date
0
Altmetric
Editorial

Open questions in the treatment of cancer pain: time for a strong evidence-based approach?

, MD PhD, , MD & , MD (Professor)

Bibliography

  • Costantini M, Ripamonti C, Beccaro M, et al. Prevalence, distress, management and relief of pain during the last three months of cancer patients’ life. Results of an Italian mortality follow-back survey. Ann Oncol 2009;20:729-35
  • Breivik H, Cherny N, Collett F, et al. Cancer-related pain: a pan European survey of prevalence, treatment, and patient attitudes. Ann Oncol 2009;20:1420-33
  • World Health Organization. Cancer pain relief. World Health Organization; Geneva: 1986
  • World Health Organization. Cancer pain relief. 2nd edition. World Health Organization; Geneva: 1996
  • Jadad AR, Browman GP. The WHO analgesic ladder for cancer pain management. Stepping up the quality of its evaluation. JAMA 1995;274(23):1870-3
  • Ripamonti CI, Bandieri E, Roila F; On behalf of the ESMO Guidelines Working Group. Management of cancer pain: ESMO Clinical Practice Guidelines. Ann Oncol 2011;22(Suppl 6):vi69-77
  • Eisenberg E, Berkey C, Carr DB, et al. Efficacy and safety of nonsteroidal antinflammatory drugs for cancer pain: a meta-analysis. J Clin Oncol 1994;12:2756-65
  • Kahan M, Mailis-Gagnon A, Wilson L, et al. Canadian guideline for safe and effective use of opioids for chronic noncancer pain: clinical summary for family physicians. Part 1: general population. Can Fam Physician 2011;57(11):1257-66; e1407-1218
  • Portenoy RK, Ahmed E. Principles of opioid use in cancer pain. J Clin Oncol 2014;16:1662-70
  • Cherny N, Ripamonti C, Pereira J, et al. Expert Working Group of the European Association of Palliative Care Network. Strategies to manage the adverse effects of oral morphine: an evidence-based report. J Clin Oncol 2001;19:2542-54
  • Mercadante S, Bruera E. Opioid switching: a systematic and critical review. Cancer Treat Rev 2006;32:304-15
  • Caraceni A, Hanks G, Kaasa S, European Palliative Care Research Collaborative (EPCRC); European Association for Palliative Care (EAPC). Use of opioid analgesics in the treatment of cancer pain: evidence-based recommendations from the EAPC. Lancet Oncol 2012;13(2):e58-68
  • Gatti A, Casali M, Lazzari M, et al. Prolonged-release oxycodone/naloxone in nonmalignant pain: single-center study in patients with constipation. Adv Ther 2013;30(1):41-59
  • Chou R. What we still don’t know about treating chronic noncancer pain with opioids. CMAJ 2010;182(9):881-2
  • Jonsson T, Christrup LL, Hojsted J, et al. Symptoms and side effects in chronic non-cancer pain: patient report vs. systematic assessment. Acta Anaesthesiol Scand 2011;55(1):69-74
  • Davies AN, Dickman A, Reid C, et al. The management of cancer-related breakthrough pain: recommendations of a task group of the Science Committee of the Association for Palliative Medicine of Great Britain and Ireland. Eur J Pain 2009;13(4):331-8
  • Mercadante S. Pharmacotherapy for breakthrough cancer pain. Drugs 2012;72:181-90
  • Pain therapy: fans in Italy are 4 times more expensive than opioids. Available from: http://www.fondazioneisal.it/en/pubblicazioni/weblog/178-cura-del-dolore-in-italia-la-spesa-per-i-fans-e-4- volte-quella-per-gli-oppiacei.html [Accessed 5 August 2014]
  • Nekolaichuk C, Fainsinger RL, Lawlor P. Challenges of conducting research on cancer pain classification: how do we make sense of the outcomes? J Palliat Med 2013;16(11):1323-5
  • Kramer M. Placebo run-in for antidepressant trials. Neuropsychopharmacology 1996;15(1):105-7
  • Powers JH, Fleming TR. Noninferiority trials: clinical understandings and misunderstandings. Clin Investig 2013;3(3):215-18
  • Glajchen M. Chronic pain: treatment barriers and strategies for clinical practice. J Am Board Fam Pract 2001;14(3):211-18
  • Nabal M, Librada S, Redondo MJ, et al. The role of paracetamol and nonsteroidal anti-inflammatory drugs in addition to WHO Step III opioids in the control of pain in advanced cancer. A systematic review of the literature. Palliat Med 2012;26:305

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.